A Randomized, Double-blind, Placebo-controlled, Single-dose, Dose-escalation Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of PMK-S005 After Oral Administration in Healthy Male Volunteers
Latest Information Update: 14 Jul 2014
At a glance
- Drugs PMK-S005 (Primary)
- Indications Gastric ulcer
- Focus Adverse reactions; Pharmacokinetics
- Sponsors PharmaKing
- 29 May 2014 Status changed from recruiting to completed; according to ClinicalTrials.gov record.
- 23 Jan 2013 New trial record